Prohance and rash Patient Reports February 13, 2012

Prohance Side Effects Report #4559727-3
Prohance side effect was reported by a Health Professional from on Feb 02, 2004. Female patient, 61 years of age, weighting 149.9 lb, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Prohance. After drug was administered, patient experienced the following side effects: anxiety , convulsion, nausea , rash , sneezing. Prohance dosage: 15 ML ONCE IV. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #5288927-2
Prohance side effect was reported by a Health Professional from UNITED STATES on Sept 05, 2006. Female patient, 24 years of age, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Prohance. After drug was administered, patient experienced the following side effects: dyspnoea, erythema, eye swelling, rash , stomatitis. Prohance dosage: 15 ML ONCE IV. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #5711112-4
Prohance side effect was reported by a Pharmacist from UNITED STATES on Apr 17, 2008. Female patient, 19 years of age, weighting 175.0 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: dizziness , flushing, headache , pruritus, rash , tremor, urticaria. Prohance dosage: 15ML -4.189GM- ONCE OVER 1 MINUTE IV. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #4559750-9
Prohance side effect was reported by a Physician from on May 05, 2004. Male patient, 37 years of age, weighting 141.1 lb, was diagnosed with back pain , nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: dyspnoea, pruritus, rash , swelling face, tremor, urticaria. Prohance dosage: 13 ML ONCE IV. During the same period patient was treated with CIPRO, NEXIUM, ULTRAM, BEXTRA. Patient was hospitalized. Patient recovered.